$44.19
Today
as of Aug 27, 09:56 ET
Last 30 days
Recent Press Releases & News
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
Overview
52-week range
$15
$50
84% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
95%
EM ±19.0% · $45 · Sep 18